Clinical presentations and outcomes of Penicillium marneffei infections: A series from 1994 to 2004

Hong Kong Medical Journal

Volumn 14, Issue 2, 2008, Pages 103-109

  Wu, T C ^a   Chan, Johnny W M ^a   Ng, C K ^a   Tsang, Dominic N C ^a   Lee, M P ^a   Li, Patrick C K ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Aids related opportunistic infections; HIV infections; Immunocompromised host; Itraconazole; Penicillium

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; ANTIFUNGAL AGENT;

ADULT; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD CULTURE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DIARRHEA; FEMALE; FEVER; HEPATOMEGALY; HONG KONG; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALAISE; MALE; MORTALITY; MYCOSIS; PATIENT CARE; PENICILLIOSIS; PENICILLIUM MARNEFFEI; PROGNOSIS; RELAPSE; SKIN DEFECT; SPLENOMEGALY; TREATMENT OUTCOME; TREATMENT RESPONSE; AIDS RELATED COMPLEX; DERMATOMYCOSIS; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; FUNGEMIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; INTRAVENOUS DRUG ADMINISTRATION; LUNG MYCOSIS; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PENICILLIUM; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADMINISTRATION, ORAL; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FUNGEMIA; HONG KONG; HUMANS; INFUSIONS, INTRAVENOUS; ITRACONAZOLE; LUNG DISEASES, FUNGAL; OPPORTUNISTIC INFECTIONS; PENICILLIUM; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 47249148014     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. DiSalvo AF, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: description of first natural infection in man. Am J Clin Pathol 1973;60:259-63.
2. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996;23:125-30.
3. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 1994;344:110-3.
4. Wong KH, Lee SS, Lo YC, et al. Profile of opportunistic infections among HIV-1 infected people in Hong Kong. Zhonghua Yi Xue Za Zhi (Taipei) 1995;55:127-36.
5. Wong KH, Lee SS. Comparing the first and second hundred AIDS cases in Hong Kong. Singapore Med J 1998;39:236-40.
6. Li PC, Tsui MC, Ma KF. Penicillium marneffei: indicator disease for AIDS in South East Asia. AIDS 1992;6:240-1.
7. Lee SS, Lo YC, Wong KH. The first one hundred AIDS cases in Hong Kong. Chin Med J (Engl) 1996;109:70-6.
8. Wong KH, Lee SS, Chan KC, Choi T. Redefining AIDS: case exemplified by Penicillium marneffei infection in HIV-infected people in Hong Kong. Int J STD AIDS 1998;9:555-6.
9. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Praparattanapan J, Nelson KE. Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand. Clin Infect Dis 1997;24:1080-6.
10. Wong SS, Wong KH, Hui WT, et al. Differences in clinical and laboratory diagnostic characteristics of Penicillium marneffei in human deficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol 2001;39:4535-40.
11. Sirisanthana T, Supparatpinyo K, Perriens J, Nelson KE. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin Infect Dis 1998;26:1107-10.
12. Supparatpinyo K, Chiewchanvit S, Hirunsri P, et al. An efficacy study of itraconazole in the treatment of Penicillium marneffei infection. J Med Assoc Thai 1992;75:688-91.
13. Supparatpinyo K, Perriens J, Nelson KE, Sirisanthana T. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. N Engl J Med 1998;339:1739-43.
14. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002;15:465-84.
15. Hopwood V, Johnson EM, Cornish JM, Foot AB, Evans EG, Warnock DW. Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J Clin Pathol 1995;48:210-3.
16. Van Cutsem J, Meulemans L, Van Gerven F, Stynen D. Detection of circulating galactomannan by Pastorex Aspergillus in experimental invasive aspergillosis. Mycoses 1990;33:61-9.
17. Supparatpinyo K, Nelson KE, Merz WG, et al. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother 1993;37:2407-11.
18. Sun HY, Chen MY, Hsiao CF, Hsieh SM, Hung CC, Chang SC. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy. Clin Microbiol Infect 2006;12:381-8.
19. Wong SS. Penicillium marneffei. In: HIV manual 2007. Hong Kong: Stanley Ho Centre for Emerging Infectious Diseases, CUHK; Centre for Health Protection, Department of Health; 2007:319-24.
20. Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect 2002;45:268-71.
21. Søndergaard J, Weismann K, Vithayasai P, Srisuwan S, Manela-Azulay M. Ethic and geographic differences and similarities of HIV/AIDS-related mucocutaneous diseases. Danida Study Groups. Int J Dermatol 1995;34:416-9.
22. Supparatpinyo K, Chiewchanvit S, Hirunsri P, Uthammachai C, Nelson KE, Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1992;14:871-4.
23. McShane H, Tang CM, Conlon CP. Disseminated Penicillium marneffei infection presenting as a right upper lobe mass in an HIV positive patient. Thorax 1998;53:905-6.
24. Wallace JM, Hansen NI, Lavange L, et al. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care 1997;155:72-80.
25. Mo W, Deng Z, Li S. Clinical blood routine and bone marrow smear manifestations of disseminated penicilliosis marneffei. Chin Med J (Engl) 2002;115:1892-4.
26. Ker CC, Hung CC, Huang SY, et al. Comparison of bone marrow studies with blood culture for etiological diagnosis of disseminated mycobacterial and fungal infection in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect 2002;35:89-93.
27. Chaiwun B, Khunamornpong S, Sirivanichai C, et al. Lymphadenopathy due to Penicillium marneffei infection: diagnosis by fine needle aspiration cytology. Mod Pathol 2002;15:939-43.
28. Holding KJ, Dworkin MS, Wan PC, et al. Aspergillus among people infected with human immunodeficiency virus: incidence and survival. Adult and Adolescent Spectrum of HIV Disease Project. Clin Infect Dis 2000;31:1253-7.
29. Jaffe HW, Selik RM. Reply: Acquired immunodeficiency syndrome: is disseminated aspergillosis predictive of underlying cellular deficiency? [letter] J Infect Dis 1984;149:829.
30. Cao L, Chan CM, Lee C, Wong SS, Yuen KY. MP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei. Infect Immun 1998;66:966-73.
31. Cao L, Chan KM, Chen D, et al. Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients. J Clin Microbiol 1999;37:981-6.
32. Cao L, Chen DL, Lee C, et al. Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicilliosis. J Clin Microbiol 1998;36:3028-31.
33. Tsui WM, Ma KF, Tsang DN. Disseminated Penicillium marneffei infection in HIV-infected subject. Histopathology 1992;20:287-93.
34. Deng Z, Ribas JL, Gibson DW, Connor DH. Infection caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 1988;10:640-52.